Biotech Business - November 18, 2025
Sofinnova announces USD 750M fund that will invest in early stage biotechs
European life science VC firm Sofinnova Partners has announced the close of its latest flagship fund, Sofinnova Capital XI, at EUR 650 million (USD 750 million).
Business article - November 18, 2025
#WAAW: Fighting AMR: Nordic efforts
Antimicrobial resistance is one of the world’s most severe global health threats but there is still hope, including several Nordic innovative solutions.
Business article - October 13, 2025
The Swedish Drug Discovery and Development Pipeline 2026
The fourteenth edition of SwedenBIO's overview of the Swedish pharmaceutical pipeline and the companies driving it has been released, detailing 152 firms engaged in 518 drug discovery and development projects.
Business article - October 6, 2025
Novo Nordisk ends collaboration with Heartseed
As part of Novo Nordisk's restructuring, the company has chosen to discontinue its cell therapy collaboration with Heartseed.
Business article - October 3, 2025
KI Innovations and AbbVie collaborate
KI Innovations, together with AbbVie Scandinavia, is launching the second edition of Golden Ticket – an initiative that gives a promising life science company the opportunity to develop its research in an internationally recognized innovation environment.
Business article - October 1, 2025
AstraZeneca BioVentureHub and Thermo Fisher Scientific announce a new partnership
The PPD clinical research business of Thermo Fisher Scientific has announced a new research and development partnership with the AstraZeneca BioVentureHub.
